Prolonged exposure to welding fumes as a novel cause of systemic iron overload.
ferritin
hepcidin
iron overload
liver fibrosis
lung
welder
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
25
02
2021
received:
28
01
2021
accepted:
04
03
2021
pubmed:
14
3
2021
medline:
29
6
2021
entrez:
13
3
2021
Statut:
ppublish
Résumé
Inhalation of welding fume may cause pulmonary disease known as welder's lung. At our centre we came across a number of welders with systemic iron overload and prolonged occupational history and we aimed at characterizing this novel clinical form of iron overload. After exclusion of other known causes of iron overload, 20 welders were fully evaluated for working history, hepatic, metabolic and iron status. MRI iron assessment was performed in 19 patients and liver biopsy in 12. We included 40 HFE-HH patients and 24 healthy controls for comparison. 75% of patients showed lung HRCT alterations; 90% had s-FERR > 1000 ng/mL and 60% had TSAT > 45%. Liver iron overload was mild in 8 and moderate-severe in 12. The median iron removed was 7.8 g. Welders showed significantly lower TSAT and higher SIS and SIS/TIS ratio than HFE-HH patients. Serum hepcidin was significantly higher in welders than in HFE-HH patients and healthy controls. At liver biopsy, 50% showed liver fibrosis that was mild in four, and moderate-severe in two. Liver staging correlated with liver iron overload. Welders with prolonged fume exposure can develop severe liver iron overload. The mechanism of liver iron accumulation is quite different to that of HFE-HH suggesting that reticuloendothelial cells may be the initial site of deposition. We recommend routine measurement of serum iron indices in welders to provide adequate diagnosis and therapy, and the inclusion of prolonged welding fume exposure in the list of acquired causes of hyperferritinemia and iron overload.
Sections du résumé
BACKGROUND & AIMS
Inhalation of welding fume may cause pulmonary disease known as welder's lung. At our centre we came across a number of welders with systemic iron overload and prolonged occupational history and we aimed at characterizing this novel clinical form of iron overload.
METHODS
After exclusion of other known causes of iron overload, 20 welders were fully evaluated for working history, hepatic, metabolic and iron status. MRI iron assessment was performed in 19 patients and liver biopsy in 12. We included 40 HFE-HH patients and 24 healthy controls for comparison.
RESULTS
75% of patients showed lung HRCT alterations; 90% had s-FERR > 1000 ng/mL and 60% had TSAT > 45%. Liver iron overload was mild in 8 and moderate-severe in 12. The median iron removed was 7.8 g. Welders showed significantly lower TSAT and higher SIS and SIS/TIS ratio than HFE-HH patients. Serum hepcidin was significantly higher in welders than in HFE-HH patients and healthy controls. At liver biopsy, 50% showed liver fibrosis that was mild in four, and moderate-severe in two. Liver staging correlated with liver iron overload.
CONCLUSIONS
Welders with prolonged fume exposure can develop severe liver iron overload. The mechanism of liver iron accumulation is quite different to that of HFE-HH suggesting that reticuloendothelial cells may be the initial site of deposition. We recommend routine measurement of serum iron indices in welders to provide adequate diagnosis and therapy, and the inclusion of prolonged welding fume exposure in the list of acquired causes of hyperferritinemia and iron overload.
Identifiants
pubmed: 33713383
doi: 10.1111/liv.14874
pmc: PMC8252060
doi:
Substances chimiques
Iron
E1UOL152H7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1600-1607Informations de copyright
© 2021 The Authors. Liver International published by John Wiley & Sons Ltd.
Références
World J Gastroenterol. 2008 Aug 14;14(30):4745-52
pubmed: 18720534
Am J Hematol. 2009 Aug;84(8):480-3
pubmed: 19536851
Scand J Gastroenterol. 2015 Apr;50(4):429-38
pubmed: 25633726
Occup Med (Lond). 2015 Dec;65(9):706-12
pubmed: 26152561
Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L417-25
pubmed: 16648237
Ann Occup Hyg. 1979;22(1):33-41
pubmed: 543579
Crit Rev Toxicol. 2003;33(1):61-103
pubmed: 12585507
Gastroenterology. 1992 Jun;102(6):2050-9
pubmed: 1587423
Hepatol Int. 2018 Mar;12(2):83-86
pubmed: 29589198
Nanomedicine. 2014 Nov;10(8):1877-86
pubmed: 24983890
Nat Rev Dis Primers. 2018 Apr 05;4:18016
pubmed: 29620054
Biochim Biophys Acta. 2009 Jul;1790(7):731-9
pubmed: 19100311
Mediterr J Hematol Infect Dis. 2009 Oct 27;1(1):e2009006
pubmed: 21415988
Arch Neurol. 1996 Aug;53(8):730-3
pubmed: 8759978
Blood. 2011 Mar 10;117(10):2953-9
pubmed: 21149632
J Hepatol. 1995 Jun;22(6):696-9
pubmed: 7560864
Gastroenterology. 1998 May;114(5):996-1002
pubmed: 9558289
Transl Gastroenterol Hepatol. 2020 Apr 05;5:25
pubmed: 32258529
Br J Haematol. 2014 Dec;167(5):692-6
pubmed: 25209728
Occup Environ Med. 2004 Jan;61(1):82-5
pubmed: 14691279
Exp Physiol. 2015 Oct;100(10):1199-216
pubmed: 26047483
Am J Med Sci. 2009 Jan;337(1):57-9
pubmed: 18941405
Liver Int. 2021 Jul;41(7):1600-1607
pubmed: 33713383
Ann Occup Hyg. 2014 Nov;58(9):1143-54
pubmed: 25223225
Liver Int. 2004 Oct;24(5):471-6
pubmed: 15482345
FASEB J. 2014 Aug;28(8):3671-8
pubmed: 24776745
Neurotoxicology. 2005 Mar;26(2):257-65
pubmed: 15713346
J Med Case Rep. 2008 Aug 05;2:257
pubmed: 18681950
Am J Clin Pathol. 2005 Dec;124(6):846-53
pubmed: 16416733
Chest. 2009 Jul;136(1):310-313
pubmed: 19584215